Arintra Raises $25M to Build Revenue Assurance Layer

Arintra is building software for the part of healthcare where clinical work becomes a financial claim. A physician can deliver the right care, document it, and still leave the provider with an incomplete code, a denial, or revenue that disappears between the chart and the payer.

The company announced a $25M Series B on August 26, 2026, led by Define Ventures. The round brings Arintra's disclosed total funding to $51M and gives the company more capital to expand beyond autonomous medical coding into a broader revenue-assurance platform for health systems.

That expansion is the actual wager. Revenue-cycle software has spent years dividing coding, documentation improvement, denials, payer rules, and audit work into separate products and queues. Arintra is trying to make the coding decision the common intelligence layer connecting them, while preserving an audit trail that shows how the system reached each answer.

What Arintra Raised and Who Invested

Define Ventures led the Series B. Existing investors Peak XV Partners, Yale New Haven Health Center for Health Care Innovation, Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Ten13, and Spider Capital participated. Endeavor Health was also an early customer and invested in both Arintra's $21M Series A in 2025 and the new round.

The financing follows a year in which Arintra expanded its product and enterprise footprint. The company says its platform now supports more than 23 specialties across ambulatory, emergency, diagnostic, and inpatient settings. It plans to add roughly two specialties per quarter, reach more enterprise health systems, deepen clinical coverage, and extend its intelligence into additional parts of the revenue cycle.

Arintra did not disclose a valuation. The company also did not break down the remaining $5M between its $21M Series A and the new $25M Series B, so the public record supports $51M in total funding without a complete round-by-round accounting of the earlier capital.

From Medical Coding to Revenue Assurance

Arintra was founded in 2020 by computer scientists Nitesh Shroff, CEO, and Preeti Bhargava, CTO. The idea grew from Bhargava's experience with a $19,000 emergency-room bill that fell substantially after billing errors were corrected. The founders initially focused on medical coding, the translation layer that turns clinical documentation into the codes used for reimbursement.

The product operates inside electronic health record systems including Epic and athenahealth. It reads the chart, applies specialty-specific coding logic, and ties generated codes back to the underlying clinical documentation. Arintra is extending that same intelligence into clinical documentation improvement, denial appeals, payer insights, and diagnosis-related group validation rather than treating each function as a separate automation project.

That architecture matters because every handoff creates another place for context to go missing. A documentation tool may capture the clinical story, a coding tool may assign the code, and a denial product may fight the payer later. The provider still owns the space between those systems. Arintra's revenue-assurance thesis is that the original coding intelligence can follow the claim through more of that journey.

Customer Results Put the Round in Context

Arintra reports that its platform processes more than $5B in annual claim value for healthcare enterprises representing more than $50B in combined net patient revenue. It also reports a 5.1% increase in compliant revenue capture, a 32% reduction in cost, and a 43% decline in coding-related denials across customers. Those portfolio-level figures come from the company and should be treated as company-reported rather than independently audited results.

One customer implementation provides more concrete detail. Mercyhealth told Healthcare IT News that its chart volume had risen above 130,000 per month while coding resources failed to scale at the same pace. After deploying Arintra inside Epic, the health system said the platform supported more than 50,000 charts per month, helped increase revenue by 5.1%, and reduced pre-accounts-receivable days by approximately 50%.

The operational change went beyond throughput. Mercyhealth said coders could move toward complex cases, denial trends, revenue integrity, provider education, and compliance work without adding full-time staff simply to chase routine volume. UC Davis Health separately said its teams were able to audit results approximately 50% faster while preserving coding quality, compliance, and clinical integrity.

KLAS Research published an Emerging Company Spotlight on Arintra in April 2026. Arintra says it earned a 93/100 customer performance score and an A+ rating. KLAS notes that emerging-company findings can change significantly as more provider organizations are interviewed, especially when the initial live-client sample is small, which is an important boundary around the signal.

Why Explainability Is the Product Test

Medical coding is not a forgiving place for an AI system to be confidently wrong. A missed code can leave legitimate revenue uncollected, but an unsupported code can create compliance, audit, and repayment risk. The commercial promise and the governance burden therefore arrive together.

Arintra's answer is an EHR-embedded audit trail that links each code to the documentation supporting it. That gives coding teams a way to validate decisions, prepare appeals, and understand why the software acted. It also creates a harder product obligation: as Arintra adds specialties, payer logic, and revenue-cycle functions, the reasoning has to remain traceable across a larger number of clinical and financial contexts.

The competitive question is not whether AI can assign codes faster. Health systems need to know whether the system can operate at enterprise scale, preserve compliance, fit existing workflows, and handle exceptions without converting every edge case into manual cleanup. The Series B gives Arintra more room to prove that its unified layer can outperform a collection of narrower tools on those terms.

What the Series B Must Prove Next

The round moves Arintra from a coding-automation story toward an infrastructure claim. The company wants medical coding to become the intelligence foundation for documentation improvement, denials, payer analysis, and other revenue-cycle work. If that works, health systems could reduce the number of disconnected decisions required to turn care into compliant reimbursement.

The remaining proof will come from expansion. Arintra must show that customer outcomes hold across more health systems, specialties, care settings, and payer environments while the audit trail remains usable to the people responsible for accuracy. It must also distinguish the value of one connected platform from the flexibility buyers get by selecting specialized products for each function.

Healthcare providers do not get a second chance to deliver the same encounter. The financial record, however, can move through several teams and systems before a claim is paid or denied. Arintra's $25M Series B is financing the belief that one explainable intelligence layer can keep those systems aligned long after the patient leaves the room.